Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.0320
0.00 (0.00%)
Aug 18, 2025, 3:47 PM EDT
Odyssey Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
3.09M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2024 | - | - | - |
| Jul 31, 2023 | - | - | - |
| Jul 31, 2022 | - | - | - |
| Jul 31, 2021 | - | - | - |
| Jul 31, 2020 | - | - | - |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 105.45M |
| Glass House Brands | 221.55M |
| American Oncology Network | 1.76B |
| Northwest Biotherapeutics | 1.09M |
| Silence Therapeutics | 27.17M |
| Longduoduo Company | 4.99M |
Odyssey Health News
- 1 year ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 1 year ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire
- 1 year ago - Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders - Accesswire
- 1 year ago - Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. - Accesswire
- 2 years ago - Odyssey Health Inc. Begins Trading on the OTCQB - Accesswire
- 2 years ago - Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS - Accesswire